Cannabis terpenes, the part of the plant which provides aroma and flavor, may provide therapeutic benefits in controlling pain, a new study reports.
A new study in Zebrafish reveals exposure to compounds found in cannabis during the early stages of development was linked to a significant drop in neural activity later in life.
A new case study reveals medical marijuana may provide rapid relief for sufferers of chronic itch. Researchers say THC attaches itself to brain receptors that influence the nervous system. This reduces inflammation and nervous system activity, leading to a reduction in itch sensation.
While cannabis users reported more psychotic experiences than non-users generally, the effect was more pronounced in those with a genetic risk factor for schizophrenia.
Smoking marijuana affects several key visual functions, including 3D vision and contrast sensitivity. However, 90% of cannabis users believe the drug has either no, or minimal, effect on their visual abilities.
A two-week course of CBD helps normalize and restore the function of two proteins associated with reducing amyloid-beta accumulation in mouse models of familial Alzheimer's disease. CBD also reduces levels of IL-6, an immune protein associated with inflammation in Alzheimer's patients.
Staphylococcal enterotoxin, a bacterial toxin implicated in some ARDS cases, can be prevented by treatment with the cannabis compound THC. Findings also suggest a potential role for using cannabinoids to treat ARDS caused by COVID-19.
High school aged girls who use marijuana experience a greater impact on their working memory and academic success than their male peers.
Examining the brains of frequent cannabis users, researchers have identified a pattern of connectivity related to craving the substance. The findings add weight to the idea that brain regions do not work in isolation, but via the connectivity of multiple networks that signal to each other depending on state and need. Brain connectivity during cannabis cravings is not static but has fluctuations in connection patterns between the central executive network and nucleus accumbens.
Multiple sclerosis patients are nine times more likely to discuss the use of alternative medicines, including cannabis, with their neurologists as treatment options than they were in 2001. 81% of MS patients report the use of dietary supplements to help with disease management, and 39% report participating in mindfulness and other mind-body therapies. 30% of patients reported using marijuana to help treat their symptoms.